AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
63.15
+3.47 (5.81%)
At close: Jun 26, 2026, 4:00 PM EDT
64.46
+1.31 (2.07%)
After-hours: Jun 26, 2026, 7:11 PM EDT
AnaptysBio Employees
AnaptysBio had 104 employees as of December 31, 2025. The number of employees decreased by 32 or -23.53% compared to the previous year.
Employees
104
Change (1Y)
-32
Growth (1Y)
-23.53%
Revenue / Employee
$2,234,500
Profits / Employee
-$257,567
Market Cap
1.84B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 243 |
| Monte Rosa Therapeutics | 187 |
| Bicara Therapeutics | 103 |
| Nanobiotix | 100 |
ANAB News
- 17 days ago - AnaptysBio assumed with a Buy at H.C. Wainwright - TheFly
- 6 weeks ago - AnaptysBio price target raised to $90 from $85 at Leerink - TheFly
- 6 weeks ago - AnaptysBio price target raised to $76 from $60 at UBS - TheFly
- 6 weeks ago - AnaptysBio price target raised to $75 from $63 at Barclays - TheFly
- 6 weeks ago - AnaptysBio reports Q1 EPS ($1.84), consensus (75c) - TheFly
- 6 weeks ago - Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - AnaptysBio Earnings release: Q1 2026 - Filings
- 6 weeks ago - AnaptysBio Quarterly report: Q1 2026 - Filings